DCX - Managed Global Payment BlockChain

[NDX-AKA]

DCX ICO listed on ICOnow.

http://iconow.net/ico-870

Good news, hopefully get closer to success.

wow good, thanks fooroo m@iconow for listing. this project willl reach softcap in the near future because this project has excellent marketing and promotion

Projects that have a very large target and are very courageous to make decisions. I'm sure this project will succeeds. I will join the campaign in this project.

[1715207806]

1715207806

[Afnan_faizah]

DCX ICO listed on ICOnow.

http://iconow.net/ico-870

Good news, hopefully get closer to success.

wow good, thanks fooroo m@iconow for listing. this project willl reach softcap in the near future because this project has excellent marketing and promotion

Projects that have a very large target and are very courageous to make decisions. I'm sure this project will succeeds. I will join the campaign in this project.

I agree with that, it seems that DCX has good marketing. I already join in DCX campaign, I will be serious in the campaign to become moderator in local thread. I wish that the token sales can reach softcap or more.

[Canoppo99]

Hi we have Indoneaian translation of Ann thread and bounty thread

CLICK LINK BELOW

ANN THREAD AND BOUNTY THREAD

[AshdiD22]

Do you negotiate with Poloniex about the listing of the tokens?

[dcxblockchain]

Hi guys,

Here you can find the Dutch white paper: https://drive.google.com/file/d/1L0YGKnS0D6d_7ZuxHJR4q7LDAU_WZWOo/view

Lol die had ik zelf ook wel kunnen schrijven  

[dcxblockchain]

Do you negotiate with Poloniex about the listing of the tokens?

Hi AshdiD22,

No we are not and we are also not going to unfortunately. Poloniex states the following on their coin info page

Some takeaways:
We cannot list any token that resembles a security. We suggest token devs familiarize themselves with The Howey Test.

as DCX token entitles to a claim to monthly receive a part of DCX exchange fee's as stated in whitepaper we do not pass the Howey test which tests if your coin/token acts as a security or not.

I will wright down your enquiry. At the moment we are looking at the possiblities to register DCX Shareholders Token at US SEC office, if we do so we will get DCX on Poloniex exchange.

For the record DCX will be listed on lots of other exchanges, we will send out news updates on which ones after ICO is ended with good results, which is needed for most echanges to be accepted and listed.

[urikmarkov]

How much is your soft cap? I see, that you end your ICO - when you reach soft cap, but didn't see the numbers.

[dcxblockchain]

Can someone explain what is going to happen with the remaining tokens not being sold?

May i will all do respect advise you to read the whitepaper before asking questions, this is fully covered in the wp.....

[dcxblockchain]

How much is your soft cap? I see, that you end your ICO - when you reach soft cap, but didn't see the numbers.

Our softcap is 2000 ETH which equals 150.000 DCX (50% presale bonus included). Also stated on the website at section "Token information" (bottom left) .

[dcxblockchain]

At first glance, the project deserves attention. I will study in more detail and, possibly, support you on the ICO.

A good approach for any invester, we are sure we will urn your trust and investment. Thnx

[LoveStory]

reserved

bounty campaign will be posted shortly.

when will be open the bounty program Sir? Interesting to joined
I see this project seems will be good and success in the future. Good luck your project.

we are planning for technical bounty campaign. please be patient 

your program seems very interesting and we are waiting for information about your campaign program hopefully we can also help this project known by the community

DCX project, with a total a hefty supply definitely later can maintain the stability of the rate market and the bounty that offered passable. Hopefully the projects run smoothly.

[Lilianaser]

reserved

bounty campaign will be posted shortly.

when will be open the bounty program Sir? Interesting to joined
I see this project seems will be good and success in the future. Good luck your project.

we are planning for technical bounty campaign. please be patient 

your program seems very interesting and we are waiting for information about your campaign program hopefully we can also help this project known by the community

very interesting project allocation for DCX bounty 7500 ETH, and the total supply 20 million come ETH. not too much, hopefully its Hard Cap reached 300, 000ETH. with the support of the great team will definitely be successful with satisfactory results.

[Jarr]

Update regarding Smith and crown will be posted soon

very great, we will wait for update about Smith and crown, this project has amazing concept, hope you will reach softcap very soon

[bestpikka]

Update regarding Smith and crown will be posted soon

very great, we will wait for update about Smith and crown, this project has amazing concept, hope you will reach softcap very soon

Yes I agree with you, I will also monitor the development of this project or not, this project will definitely be good going forward, and the allocation of the bounty hunter lots up to 7500 ETH. and when reaching the softcap if in pre-sale has reached 2000 eth already have a condition. Moreover, supply's not how likely softcap will be achieved

[Canoppo99]

Hello we have Chinese translation of Ann thread

CLICK LINK BELOW


ANN THREAD

[Jarr]

Hello we have Chinese translation of Ann thread

CLICK LINK BELOW


ANN THREAD

Chinese will bring many investors and supporters, usually in Chinese ann thread, the topic will discussed by mqny people there.
hope the translator of Chinese will moderate the topic nicely.

[Canoppo99]

UPDATE :

DCX proudly announce about a new advisor.
DCX is growing and supported by Advisor for helping the project.

Andrey Voronkov - Co-founder of SONM

Andre Voronkov is a Scientific researcher, working in the field of computational chemistry, chemoinformatics and medicinal chemistry. \
– PhD degree in bioorganic chemistry and biochemistry
– The completed projects include full-scale drug development of preclinical anti-cancer drug candidates in collaboration with Novo Nordisk and Genentech companies.


Areas of competence include preclinical drug discovery, ADME/Tox optimization, molecular modeling and medicinal chemistry. Expertise in all aspects of chemoinformatics, molecular modeling and drug design. Expertise with virtual screening, library design, QSAR, data mining methods, and modeling tools development, computer-aided drug design, fragment-based approaches, molecular modeling, chemo- and bioinformatics, medicinal chemistry, and target analysis and selection. Optimization of physico-chemical parameters for ADME/Tox and DMPK.
Experienced user of the following software packages: MOE from CCG, Sybyl from Certara, Accelyrs Insight and Discovery studio, OpenEye, Schrödinger suite, Vortex / PipelinePilot. Solid background in chemistry, biology, IT, statistics, and mathematics. Expertise in using HPLC, NMR and MS for organic chemistry applications.
The next fields of research are in scope of the interests:
– Applications development for chemoinformatics and modeling methods and tools.
– Collaboration and research in the interdisciplinary teams of chemists, medicinal chemists, biologists and software developers for the analysis and visualization of scientific data
– Processing and evaluation of commercial and virtual libraries for their suitability for HT screening against targets of interest
– Ligand-based and structure-based models construction for improvement of the compounds potency (using pharmacaphore models/QSAR/multivariate approaches)
– Virtual screening and high-throughput screening methodologies optimization

Great news, the advisor will lead DCX to success.

[dasher797]

UPDATE :

DCX proudly announce about a new advisor.
DCX is growing and supported by Advisor for helping the project.

Andrey Voronkov - Co-founder of SONM

Andre Voronkov is a Scientific researcher, working in the field of computational chemistry, chemoinformatics and medicinal chemistry. \
– PhD degree in bioorganic chemistry and biochemistry
– The completed projects include full-scale drug development of preclinical anti-cancer drug candidates in collaboration with Novo Nordisk and Genentech companies.


Areas of competence include preclinical drug discovery, ADME/Tox optimization, molecular modeling and medicinal chemistry. Expertise in all aspects of chemoinformatics, molecular modeling and drug design. Expertise with virtual screening, library design, QSAR, data mining methods, and modeling tools development, computer-aided drug design, fragment-based approaches, molecular modeling, chemo- and bioinformatics, medicinal chemistry, and target analysis and selection. Optimization of physico-chemical parameters for ADME/Tox and DMPK.
Experienced user of the following software packages: MOE from CCG, Sybyl from Certara, Accelyrs Insight and Discovery studio, OpenEye, Schrödinger suite, Vortex / PipelinePilot. Solid background in chemistry, biology, IT, statistics, and mathematics. Expertise in using HPLC, NMR and MS for organic chemistry applications.
The next fields of research are in scope of the interests:
– Applications development for chemoinformatics and modeling methods and tools.
– Collaboration and research in the interdisciplinary teams of chemists, medicinal chemists, biologists and software developers for the analysis and visualization of scientific data
– Processing and evaluation of commercial and virtual libraries for their suitability for HT screening against targets of interest
– Ligand-based and structure-based models construction for improvement of the compounds potency (using pharmacaphore models/QSAR/multivariate approaches)
– Virtual screening and high-throughput screening methodologies optimization

So the advisor is a part of SONM, okay it is good for your project. How do you convince to investor that this is good project? There are many project out there, why we should choose your project? What is the biggest challenge that will be face in the future?.

[Ausgewielt]

This project is look good. But I will learn more about your project.

[Markzuckertion]

So it is asset backed token, and the price is keep as is. Its mean that if I buy DCX now with 50% bonus, I definitely get 100% profit. Is this right?